Stock listing
Frankfurt:1L7 Epiminder Ltd. Aktie
German listing (Frankfurt) of Epiminder Ltd. · home listing ASX:EPI
Follow Epiminder Ltd. into a list and get an email when it puts out news.
Home listing price · ASX:EPI
$0.255 AUD -0.015 (-5.6%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, ASX:EPI
- Day range
- $0.255 – $0.280 AUDNov 20, 2026
- Volume
- 99,938 sharesNov 20, 2026
- Market cap
- $55.25M AUDAt the close on Nov 20, 2026 · price × 216.7M shares outstanding
- Traded on an average day
- $29,860 AUDMedian day 70,384 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:EPI · Home | $0.255 AUD | -0.015 (-5.6%) | 99,938 | $0.280 | $0.280 | $0.255 | $0.270 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:EPI · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.255 | -0.015 | -5.6% | $0.280 | $0.280 | $0.255 | 99,938 | |
| $0.270 | 0.000 | 0.0% | $0.270 | $0.277 | $0.265 | 162,872 | |
| $0.270 | -0.005 | -1.8% | $0.285 | $0.290 | $0.270 | 61,878 | |
| $0.275 | 0.000 | 0.0% | $0.275 | $0.275 | $0.275 | 0 | |
| $0.275 | +0.005 | +1.9% | $0.265 | $0.280 | $0.265 | 133,547 | |
| $0.270 | -0.010 | -3.6% | $0.280 | $0.280 | $0.270 | 72,710 | |
| $0.280 | -0.010 | -3.4% | $0.290 | $0.290 | $0.280 | 79,785 | |
| $0.290 | +0.035 | +13.7% | $0.265 | $0.290 | $0.265 | 236,906 | |
| $0.255 | -0.010 | -3.8% | $0.265 | $0.265 | $0.255 | 61,630 | |
| $0.265 | +0.025 | +10.4% | $0.265 | $0.265 | $0.255 | 371,182 | |
| $0.240 | -0.020 | -7.7% | $0.265 | $0.270 | $0.240 | 75,012 | |
| $0.260 | +0.005 | +2.0% | $0.265 | $0.265 | $0.255 | 29,826 | |
| $0.255 | +0.005 | +2.0% | $0.250 | $0.255 | $0.250 | 29,880 | |
| $0.250 | -0.015 | -5.7% | $0.265 | $0.265 | $0.240 | 130,923 | |
| $0.265 | 0.000 | 0.0% | $0.265 | $0.265 | $0.260 | 59,586 | |
| $0.265 | -0.005 | -1.9% | $0.265 | $0.265 | $0.265 | 688 | |
| $0.270 | +0.005 | +1.9% | $0.270 | $0.280 | $0.265 | 156,687 | |
| $0.265 | +0.010 | +3.9% | $0.270 | $0.270 | $0.265 | 7,887 | |
| $0.255 | -0.010 | -3.8% | $0.255 | $0.255 | $0.255 | 13,931 | |
| $0.265 | -0.005 | -1.9% | $0.270 | $0.270 | $0.265 | 31,930 | |
| $0.270 | 0.000 | 0.0% | $0.270 | $0.270 | $0.270 | 42,543 | |
| $0.270 | -0.012 | -4.4% | $0.275 | $0.275 | $0.270 | 15,500 | |
| $0.283 | +0.012 | +4.6% | $0.275 | $0.283 | $0.275 | 22,659 | |
| $0.270 | -0.015 | -5.3% | $0.290 | $0.290 | $0.270 | 17,935 | |
| $0.285 | 0.000 | 0.0% | $0.290 | $0.290 | $0.280 | 66,620 | |
| $0.285 | +0.005 | +1.8% | $0.280 | $0.290 | $0.270 | 201,620 | |
| $0.280 | -0.005 | -1.8% | $0.280 | $0.280 | $0.280 | 5,587 | |
| $0.285 | 0.000 | 0.0% | $0.295 | $0.295 | $0.280 | 122,298 | |
| $0.285 | -0.010 | -3.4% | $0.295 | $0.295 | $0.285 | 51,988 | |
| $0.295 | 0.000 | 0.0% | $0.295 | $0.295 | $0.290 | 57,309 | |
| $0.295 | 0.000 | 0.0% | $0.295 | $0.295 | $0.290 | 13,946 | |
| $0.295 | +0.025 | +9.3% | $0.320 | $0.330 | $0.290 | 70,227 | |
| $0.270 | +0.005 | +1.9% | $0.260 | $0.270 | $0.260 | 99,913 | |
| $0.265 | +0.005 | +1.9% | $0.260 | $0.265 | $0.260 | 28,459 | |
| $0.260 | -0.005 | -1.9% | $0.260 | $0.260 | $0.258 | 66,063 | |
| $0.265 | +0.005 | +1.9% | $0.263 | $0.265 | $0.260 | 60,946 | |
| $0.260 | 0.000 | 0.0% | $0.250 | $0.260 | $0.250 | 70,540 | |
| $0.260 | -0.015 | -5.5% | $0.270 | $0.270 | $0.250 | 111,067 | |
| $0.275 | -0.015 | -5.2% | $0.290 | $0.295 | $0.270 | 52,523 | |
| $0.290 | +0.010 | +3.6% | $0.290 | $0.290 | $0.290 | 71,287 | |
| $0.280 | +0.015 | +5.7% | $0.270 | $0.285 | $0.270 | 213,975 | |
| $0.265 | +0.015 | +6.0% | $0.265 | $0.270 | $0.250 | 140,821 | |
| $0.250 | -0.030 | -10.7% | $0.280 | $0.280 | $0.250 | 569,151 | |
| $0.280 | -0.010 | -3.4% | $0.290 | $0.290 | $0.280 | 127,763 | |
| $0.290 | 0.000 | 0.0% | $0.295 | $0.295 | $0.290 | 26,705 | |
| $0.290 | +0.005 | +1.8% | $0.290 | $0.300 | $0.285 | 186,896 | |
| $0.285 | +0.005 | +1.8% | $0.285 | $0.285 | $0.285 | 40,526 | |
| $0.280 | -0.020 | -6.7% | $0.300 | $0.300 | $0.280 | 130,417 | |
| $0.300 | 0.000 | 0.0% | $0.308 | $0.308 | $0.300 | 65,633 | |
| $0.300 | -0.005 | -1.6% | $0.305 | $0.305 | $0.300 | 48,365 | |
| $0.305 | -0.005 | -1.6% | $0.315 | $0.315 | $0.300 | 42,512 | |
| $0.310 | -0.005 | -1.6% | $0.310 | $0.355 | $0.310 | 138,246 | |
| $0.315 | +0.003 | +0.8% | $0.320 | $0.320 | $0.315 | 59,389 | |
| $0.313 | -0.008 | -2.3% | $0.330 | $0.330 | $0.305 | 129,948 | |
| $0.320 | 0.000 | 0.0% | $0.330 | $0.330 | $0.315 | 243,708 | |
| $0.320 | -0.005 | -1.5% | $0.325 | $0.340 | $0.320 | 121,598 | |
| $0.325 | -0.025 | -7.1% | $0.350 | $0.350 | $0.300 | 222,496 | |
| $0.350 | +0.010 | +2.9% | $0.360 | $0.360 | $0.335 | 116,815 | |
| $0.340 | -0.010 | -2.9% | $0.360 | $0.360 | $0.340 | 20,138 | |
| $0.350 | -0.015 | -4.1% | $0.365 | $0.365 | $0.350 | 35,424 | |
| $0.365 | +0.005 | +1.4% | $0.350 | $0.365 | $0.348 | 19,275 | |
| $0.360 | -0.045 | -11.1% | $0.405 | $0.405 | $0.340 | 237,694 | |
| $0.405 | 0.000 | 0.0% | $0.400 | $0.415 | $0.400 | 75,915 | |
| $0.405 | -0.055 | -12.0% | $0.450 | $0.450 | $0.400 | 305,841 | |
| $0.460 | 0.000 | 0.0% | $0.465 | $0.470 | $0.455 | 96,978 | |
| $0.460 | +0.020 | +4.5% | $0.460 | $0.465 | $0.445 | 135,456 |
- Ticker
- Frankfurt:1L7
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 16, 2026
Strategic partnership with leading US EEG provider
Latest deck · Oct 30, 2026
Shareholder Meeting (October 2026)
Shareholder meeting · 30 slides
Latest news
Strategic partnership with leading US EEG provider
Nov 16, 2026
Closed $0.27 (-1.8%) on Nov 17, 2026
Change of Address Update
Nov 12, 2026
Closed $0.275 (+1.9%) on Nov 13, 2026
CMS Increases Medicare Payment for the Minder System CY 2027
Nov 5, 2026
Closed $0.265 (+10.4%) on Nov 6, 2026
Resignation of Chief Financial Officer
Nov 3, 2026
Closed $0.26 (+2.0%) on Nov 4, 2026
Change of Address
Nov 2, 2026
Closed $0.255 (+2.0%) on Nov 3, 2026
Results of Annual General Meeting
Oct 29, 2026
Closed $0.265 (0.0%) on Oct 30, 2026
Minder System Cleared for Patients 12 -75 Years of Age
Oct 29, 2026
Closed $0.265 (0.0%) on Oct 30, 2026
FY27 YTD operational update and AGM materials
Oct 29, 2026
Closed $0.265 (0.0%) on Oct 30, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
Oct 27, 2026
Closed $0.27 (+1.9%) on Oct 28, 2026
100th patient enrolled in US study ahead of schedule
Oct 14, 2026
Closed $0.285 (+1.8%) on Oct 15, 2026
Epiminder Ltd. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 35 in the last 12 months · 35 in all · newest Nov 16, 2026 · oldest 2025
- Decks
- 3 decks · latest Oct 30, 2026
Where Epiminder Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:EPI · Home listing | ASX | Australia | AUD |
| Dusseldorf:1L7 | Dusseldorf | Germany | EUR |
| Frankfurt:1L7 · This page | Frankfurt | Germany | EUR |
Valuation
Price/book 0.7× against a median of 1.3×: 3rd lowest of 9 Medical devices & supplies companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$20.54M AUD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.7×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Epiminder Ltd. · ASX:EPI | US$36.57M | −US$13.60M | n/a | n/a | n/a | 0.7× | n/a | 0.0× | n/a |
| electroCore, Inc. · NASDAQ:ECOR | US$40.78M | US$41.51M | n/a | 1.1× | n/a | n/a | −33.5% | n/a | 1.91 |
| Elutia, Inc. · NASDAQ:ELUT | US$39.86M | US$18.87M | 0.7× | 1.5× | n/a | 2.6× | 441.2% | 0.5× | -0.06 |
| DRGEM Corp. · KRX:263690 | US$38.81M | US$32.33M | 4.3× | 0.4× | 3.2× | 0.5× | 11.2% | 0.1× | n/a |
| Cryofocus Medtech (Shanghai) Co. Ltd. Class H · HKEX:6922 | US$37.93M | US$29.03M | n/a | 2.0× | n/a | 3.8× | −40.1% | 0.0× | n/a |
| Ocumetics Technology Corp · TSXV:OTC | US$37.38M | US$37.60M | n/a | n/a | n/a | n/a | n/a | n/a | 0.14 |
| Optomed Oyj Class A · OMXHEX:OPTOMED | US$37.24M | US$32.48M | n/a | 1.8× | n/a | 1.6× | −33.9% | 0.1× | n/a |
| Sensus Healthcare, Inc. · NASDAQ:SRTS | US$37.20M | US$24.56M | n/a | 1.5× | n/a | 1.1× | −96.5% | 0.0× | 1.08 |
| Avita Corporation · TPEX:4735 | US$35.63M | US$14.80M | 5.1× | 0.5× | 4.4× | 1.0× | 23.8% | 0.0× | n/a |
| SELVAS Healthcare, Inc. · KRX:208370 | US$35.56M | US$15.07M | 5.5× | 0.6× | 8.0× | 0.6× | 27.5% | 0.0× | n/a |
| Taiwan Biomaterial Co., Ltd. · TPEX:6649 | US$35.55M | US$28.06M | 35.3× | 5.1× | 26.5× | 1.8× | 18.2% | 0.0× | n/a |
| Median of the others | US$37.31M | US$28.55M | 5.1× | 1.5× | 6.2× | 1.3× | 11.2% | 0.0× | 0.61 |
Forecasts
Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 2.22 AUD · Analysts' mean
- EPS, year to Jun 2027
- -0.20 · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Rohan Hoare | Chief Executive Officer & Managing Director |
| John Heasman | Chief Operating Officer |
| Chip Moebus | VP, Market Access |
| Melita Lambiris | VP, Quality & Regulatory |
| Steven Ringo | VP, IT & Security |
| Tracy Cameron | VP, Clinical & Regulatory |
| Mark Cook | Chief Medical Officer |
| Toby McSweeney | Chief Technology Officer |
Board
| Director | Role |
|---|---|
| Philip Binns | Chair |
| Donal O'Dwyer | Independent Non-Executive Director |
| Jeff Sells | Independent Non-Executive Director |
| Patricia O'Rourke | Non-Executive Director |
| Robert Klupacs | Non-Executive Director |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (October 2026) | Shareholder meeting | 30 slides | Oct 30, 2026 |
| Investor Presentation (July 2026) | Investor deck | 29 slides | Jul 30, 2026 |
| H1 FY2026 Earnings Presentation | Earnings | 20 slides | Feb 25, 2026 |
Financials
Annual, in AUD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | 445.2K | 6.56M | 5.49M | |
| Cost of revenue | 4.00M | |||
| Gross profit | -4.00M | |||
| Research and development | 17.2M | |||
| Selling, general and administrative | 16.1M | 14.4M | 9.36M | 7.42M |
| Operating income | -43.6M | -29.8M | -14.1M | -15.1M |
| Depreciation and amortization | 39.0K | 68.0K | 92.0K | 82.8K |
| EBITDA | -43.6M | -29.8M | -14.0M | -15.1M |
| Interest expense | 1.22M | 3.04M | 1.95M | 1.01M |
| Income before tax | -42.7M | -31.8M | -15.9M | -16.1M |
| Net income | -42.7M | -31.8M | -15.9M | -16.1M |
| Earnings per share, basic | -0.20 | -0.18 | -0.07 | -0.07 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Cash and equivalents | 75.8M | 117.0M | 11.3M | 11.2M |
| Receivables | 383.3K | 5.91M | 8.30M | |
| Current assets | 77.6M | 117.5M | 17.6M | 20.0M |
| Property, plant and equipment | 70.6K | 62.5K | 28.7K | |
| Total assets | 90.8M | 130.7M | 34.2M | 36.6M |
| Accounts payable | 1.85M | 22.6M | ||
| Current liabilities | 7.97M | 23.2M | 5.90M | 8.81M |
| Long-term debt | 48.0M | 36.0M | 26.3M | |
| Total liabilities | 9.17M | 23.3M | 42.0M | 35.2M |
| Shareholders' equity | 81.7M | 107.4M | -7.79M | 1.39M |
| Shares outstanding | 216.7M | 175.2M | 216.7M | 216.7M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Cash from operations | -17.0M | -13.8M | -14.2M | |
| Capital spending | 0 | -38.1K | -49.8K | -25.1K |
| Free cash flow | -17.0M | -13.8M | -14.3M | |
| Cash from investing | -38.1K | -49.8K | -25.1K | |
| Cash from financing | 110.0M | 14.6M | 14.0M | 10.4M |
| Share buybacks | -9.56M | 0 | 5.54M | 0 |
| Change in cash | 66.7M | -2.46M | 140.2K | -3.92M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Strategic partnership with leading US EEG provider | Nov 16, 2026 | Operations update | ASX |
| Change of Address Update | Nov 12, 2026 | Other filings | ASX |
| CMS Increases Medicare Payment for the Minder System CY 2027 | Nov 5, 2026 | Guidance | ASX |
| Resignation of Chief Financial Officer | Nov 3, 2026 | Management or board change | ASX |
| Change of Address | Nov 2, 2026 | Other filings | ASX |
| Results of Annual General Meeting | Oct 29, 2026 | Meeting outcome | ASX |
| Minder System Cleared for Patients 12 -75 Years of Age | Oct 29, 2026 | Operations update | ASX |
| Minder System Cleared for Patients 12 -75 Years of Age | Oct 29, 2026 | Operations update | ASX |
| FY27 YTD operational update and AGM materials | Oct 29, 2026 | Operations update | ASX |
| FY27 YTD operational update and AGM materials | Oct 29, 2026 | Operations update | ASX |
All 34 filings
Cap table
Built by 6ix from Epiminder Ltd.’s releases
- Common shares
- 216,671,652
- Fully diluted
- 216,671,652
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 216,671,652 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 216,671,652 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Chip Moebus | VP, Market Access · Since at least Nov 4, 2026 |
| Donal O'Dwyer | Independent Non-Executive Director · Since at least Nov 5, 2026 |
| Jeff Sells | Independent Non-Executive Director · Since at least Nov 4, 2026 |
| John Heasman | Chief Operating Officer · Since at least Nov 4, 2026 |
| Mark Cook | Chief Medical Officer · Since at least Nov 4, 2026 |
| Mark McLellan | Chief Financial Officer and Company Secretary · Nov 3, 2026 – Nov 3, 2026 · Past |
| Melita Lambiris | VP, Quality & Regulatory · Since at least Nov 4, 2026 |
| Patricia O'Rourke | Non-Executive Director · Since at least Nov 5, 2026 |
| Philip Binns | Chair · Since at least Nov 4, 2026 |
| Robert Klupacs | Non-Executive Director · Since at least Nov 5, 2026 |
All 14 people
| Person | Seat |
|---|---|
| Rohan Hoare | Chief Executive Officer & Managing Director · Since at least Nov 5, 2026 |
| Steven Ringo | VP, IT & Security · Since at least Nov 4, 2026 |
| Toby McSweeney | Chief Technology Officer · Since at least Nov 4, 2026 |
| Tracy Cameron | VP, Clinical & Regulatory · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Epiminder Ltd.